课题基金 / 基金详情

BIOMARKER PROFILES AS PREDICATORS OF NEONATAL SEPSIS AND RECOVERY

BIOMARKER PROFILES AS PREDICATORS OF NEONATAL SEPSIS AND RECOVERY
生物标志物概况作为新生儿败血症和恢复的预测因子
批准号:
7952072
负责人:
ROBIN K OHLS
金额:
$8.43万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-01 至 2009-11-30

项目摘要

项目成果

ROBIN K OHLS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Bacterial blood infection is a frequent and serious problem in neonatal intensive care units, particularly in very low birth weight infants. Diagnosis by blood culture is difficult, time consuming, and lacks sensitivity. Over 20% of all very low birth weight infants experience one or more episodes of late onset sepsis [defined as any sepsis occurring after 3 days of age]. The median age for the first episode of late onset sepsis is 17 days. Delaying treatment until symptoms arise can be life threatening. On the other hand, recurrent treatment with antimicrobial agents in infants that are not infected holds potential risks to these infants by furthering the development of resistant organisms. This therefore, is an ideal population to evaluate to develop a rapid and sensitive product to identify infection. Newborns [especially premature infants or those with very low birth weight] are at much greater risk for life-threatening infections than older children and adults. Diagnosing these infections is difficult with current laboratory methods. Because of the life-threatening nature of these infections, infants in the Newborn Intensive Care Unit [NICU] are almost always placed on powerful antibiotics until we can confirm whether or not an infection is truly present. While these medications are necessary, using them too frequently can cause germs to develop resistance, which prevents the antibiotics from being effective. The purpose of this research study is to investigate a new laboratory method of diagnosing infections in newborns using a single drop of blood. From this small amount of blood we can test for markers of infection. We will be looking for markers that would suggest that an infant is infected. We intend to compare these tests with current methods in order to find out if we can diagnose serious infections more quickly. This may allow us to avoid treating infants with antibiotics when they are not needed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Darbepoetin Trial to Improve Red Cell Mass and Neurodevelopment in Preterms-CCC
  • 批准号:
    10152693
  • 项目类别:
  • 资助金额:
    $31.61万
  • 财政年份:
    2019
  • 负责人:
    ROBIN K OHLS
  • 依托单位:
Darbepoetin Trial to Improve Red Cell Mass and Neurodevelopment in Preterms-CCC
  • 批准号:
    9899664
  • 项目类别:
  • 资助金额:
    $36.0万
  • 财政年份:
    2019
  • 负责人:
    ROBIN K OHLS
  • 依托单位:
NICHD Cooperative Multicenter Neonatal Research Network - Utah Center
  • 批准号:
    9899864
  • 项目类别:
  • 资助金额:
    $28.14万
  • 财政年份:
    2016
  • 负责人:
    ROBIN K OHLS
  • 依托单位:
NICHD Cooperative Multicenter Neonatal Research Network - Utah Center
  • 批准号:
    10682083
  • 项目类别:
  • 资助金额:
    $34.49万
  • 财政年份:
    2016
  • 负责人:
    ROBIN K OHLS
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: